PFE Valuation

Pfizer Inc

Add to Watchlist

Advanced Chart

25.140

+0.88(3.627%)1D

Overview
Forecast
Valuation
Earnings

PFE Relative Valuation

PFE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PFE is overvalued; if below, it's undervalued.

Historical Valuation

Pfizer Inc (PFE) is now in the Fair zone, suggesting that its current forward PE ratio of 8.90 is considered Fairly compared with the five-year average of 12.60. The fair price of Pfizer Inc (PFE) is between 23.07 to 51.22 according to relative valuation methord.

Relative Value

Fair Zone

23.07-51.22

Current Price：25.14

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.58

P/B

Median3y

2.03

Median5y

2.58

8.13

FCF Yield

Median3y

6.22

Median5y

6.99

Competitors Valuation Multiple

The average P/S ratio for PFE's competitors is 3.98, providing a benchmark for relative valuation. Pfizer Inc Corp (PFE) exhibits a P/S ratio of 2.22, which is -44.24% above the industry average. Given its robust revenue growth of -7.82%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap